Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases."

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

Scientists from Vanderbilt University and Vanderbilt University Medical Center led several activities to illustrate the important roles that microorganisms play in the environment and human health.

The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways.

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

The six-month-long “Visualizing Virology” residency is an extension of the VI4 Artist-in-Residence Program established in 2019 by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), and supported by the Burroughs Wellcome Fund.